For Immediate Assistance Call 1-800-966-2244
Mesothelioma Asbestos Mesothelioma Resources Mesothelioma Attorneys Mesothelioma Settlements Mesothelioma Claims

Study of Patients With Malignant Pleural Mesothelioma Cancers

This study is collecting and examining tissue, blood, and urine samples from patients with non-small cell lung cancer, esophageal cancer, malignant pleural mesothelioma, mediastinal or chest wall neoplasms, or lung metastases from cancers of non-thoracic origin.

Collecting and storing samples of tissue, blood, and urine from patients with cancer to study in the laboratory may help the study of cancer. It may also help doctors identify patients who are eligible for clinical trials.

  • Start Date: November 2005
  • Primary Completion Date: Unknown
  • Completion Date: Unknown
  • Last Updated Date: June 16, 2010

Disease Characteristics

  • Histologically or cytologically confirmed or radiographic evidence of primary non-small cell lung cancer, esophageal cancer, malignant pleural mesothelioma, mediastinal or chest wall neoplasms, or pulmonary metastases from cancers of non-thoracic origin
  • Intracranial metastases potentially treatable with surgery and/or radiotherapy allowed

Patient Characteristics

  • ECOG performance status 0-2
  • ANC ≥ 1,000/mm³
  • Platelet count ≥ 75,000/mm³
  • PT ≤ 16 OR INR ≤ 2
  • Creatinine < 2.5 g/dL
  • Bilirubin ≤ 2 times upper limit of normal

Please refer to this study by its ClinicalTrials.gov identifier: NCT00447447.

For more information on how to participate in this clinical trial, please contact the following location:

Warren Grant Magnuson Clinical Center
Bethesda, Maryland 20892
Contact: 888-NCI-1937

Find More Information on